Low platelet count, medically known as thrombocytopenia, is a serious condition that can increase the risk of bleeding and bruising. It is commonly seen in disorders such as immune thrombocytopenic purpura (ITP), chronic liver disease, and in patients undergoing certain medical treatments. Managing platelet levels safely and effectively is essential to improve patient outcomes and quality of life.
LTROLAMINE 25 contains Eltrombopag Olamine Tablets 25 mg, a well-established thrombopoietin receptor agonist. This medicine works by stimulating platelet production in the bone marrow, helping the body restore and maintain healthy platelet counts. LTROLAMINE 25 is widely prescribed by specialists for patients who do not respond adequately to conventional therapies.
Designed to meet the needs of the Indian healthcare landscape, LTROLAMINE 25 offers reliable platelet support with convenient oral administration, making it suitable for long-term management under medical supervision.
Uses
Eltrombopag Olamine Tablets 25 mg are used in the management of conditions associated with low platelet levels. LTROLAMINE 25 is commonly prescribed for:
Immune Thrombocytopenic Purpura (ITP): Helps increase platelet count in adults and children who have not responded well to corticosteroids, immunoglobulins, or splenectomy.
Chronic Hepatitis C–related Thrombocytopenia: Supports platelet production to enable patients to continue antiviral therapy safely.
Severe Aplastic Anemia: Used when patients show an insufficient response to immunosuppressive therapy.
Prevention of Bleeding Risks: By improving platelet levels, it reduces the risk of spontaneous bleeding and bruising.
Long-term Platelet Management: Helps maintain stable platelet counts with regular monitoring.
LTROLAMINE 25 plays a vital role in improving clinical stability and reducing complications related to low platelet counts.
Benefits
LTROLAMINE 25 offers multiple clinical and practical benefits for patients with thrombocytopenia:
Stimulates Natural Platelet Production: Activates thrombopoietin receptors in the bone marrow, encouraging platelet formation.
Reduces Bleeding Episodes: Helps lower the risk of bleeding, including gum bleeding, nosebleeds, and internal bleeding.
Oral Tablet Convenience: Easy-to-take tablet improves patient compliance compared to injectable therapies.
Supports Ongoing Treatments: Enables patients with hepatitis C or other chronic conditions to continue essential therapies.
Improves Quality of Life: Stable platelet levels allow patients to carry out daily activities with greater confidence.
Flexible Dose Strength: The 25 mg strength allows doctors to individualize treatment based on patient response.
Clinically Proven Efficacy: Backed by studies showing sustained platelet count improvement with proper monitoring.
These benefits make LTROLAMINE 25 a trusted choice for long-term platelet management.
Dosage
The dosage of LTROLAMINE 25 Eltrombopag Olamine Tablets 25 mg depends on the patient’s condition, platelet count, age, and response to treatment.
General dosage guidelines include:
Typically started at 25 mg once daily, especially in patients of East Asian descent or those with liver impairment.
The dose may be adjusted gradually based on platelet response.
Tablets should be taken once daily on an empty stomach, at least 1 hour before or 2 hours after meals.
Avoid taking LTROLAMINE 25 with dairy products, calcium supplements, iron, or antacids, as these can reduce absorption.
Important administration tips:
Take the tablet at the same time every day.
Do not crush or chew the tablet.
Regular blood tests are essential to monitor platelet levels and liver function.
Dosage adjustments should always be done under medical supervision.
Side Effects of LTROLAMINE 25
Like all medicines, LTROLAMINE 25 may cause side effects in some patients. Most side effects are mild to moderate and manageable with monitoring.
Common side effects may include:
Headache
Nausea or vomiting
Fatigue
Diarrhea
Muscle or joint pain
Less common but important side effects:
Elevated liver enzymes
Skin rash or itching
Dizziness
Increased risk of blood clots if platelet count rises excessively
Rare but serious side effects:
Severe liver problems
Thromboembolic events (blood clots)
Patients should inform their doctor immediately if they notice unusual symptoms such as severe abdominal pain, yellowing of skin or eyes, or sudden swelling in limbs.
Precautions and Warning
Before starting LTROLAMINE 25, certain precautions should be carefully considered:
Liver Function Monitoring: Regular liver tests are required, as eltrombopag can affect liver enzymes.
Risk of Blood Clots: Platelet levels should not be raised beyond the recommended range.
Pregnancy and Breastfeeding: Use only if clearly advised by a doctor.
Drug Interactions: Inform your physician about all medicines, supplements, and herbal products being taken.
Dietary Restrictions: Avoid calcium-rich foods close to dosing time.
Long-term Use: Continuous monitoring is essential for patients on prolonged therapy.
LTROLAMINE 25 should be used strictly under specialist guidance to ensure safety and effectiveness.
Conclusion
LTROLAMINE 25 Eltrombopag Olamine Tablets 25 mg is a clinically trusted solution for managing low platelet counts associated with immune thrombocytopenia, chronic liver disease, and aplastic anemia. By stimulating natural platelet production, it significantly reduces bleeding risks and supports long-term disease management.With its convenient oral dosing, proven efficacy, and flexible treatment approach, LTROLAMINE 25 improves patient confidence and quality of life when used responsibly. Regular monitoring and adherence to medical advice ensure optimal results and safety.
